Your browser doesn't support javascript.
loading
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center.
Valenza, Carmine; De Pas, Tommaso Martino; Gaeta, Aurora; Castellano, Grazia; Santoro, Celeste; Corona, Amedeo; Chiappini, Giulia; Vivanet, Grazia; Trapani, Dario; Coppola, Sara; Conforti, Fabio; Mattar, Denise; Gandini, Sara; Veronesi, Paolo; Pennacchioli, Elisabetta; Curigliano, Giuseppe.
  • Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • De Pas TM; Medical Oncology Division, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
  • Gaeta A; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Castellano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Santoro C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Corona A; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
  • Chiappini G; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
  • Vivanet G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Coppola S; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
  • Conforti F; Medical Oncology Division, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
  • Mattar D; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
  • Gandini S; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Veronesi P; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
  • Pennacchioli E; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
  • Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.
Eur J Cancer ; 196: 113423, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37977104
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Tumor Filoide Límite: Female / Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Tumor Filoide Límite: Female / Humans Idioma: En Año: 2024 Tipo del documento: Article